FDA just approved the drug for asthma this week. PI- McQuaid Read Full Article Category: NewsBy PulmonixJune 28, 2018Post navigationPreviousPrevious post:New COPD Triple InhalerNextNext post:LeBauer HealthCare Selected for Prestigious Pulmonary Fibrosis NetworkRelated PostsEffect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary FibrosisMarch 30, 2023September is Pulmonary Fibrosis Awareness Month #PFAM2022 and #BlueUpForPFSeptember 26, 2022Importance of Clinical TrialsAugust 26, 2022Cone Health Medical Staff Honors Its ‘Health Care Heroes’October 6, 2021
Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary FibrosisMarch 30, 2023
